When was Biogen founded?

Biogen was founded in 1978 and raised its 1st funding round 5 years after it was founded.

Where is Biogen located?

Biogen is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts.

How many employees does Biogen have?

As of Jul 31, 2026, the latest employee count at Biogen is 7805.

Is Biogen a funded company?

Biogen is a funded company, having raised a total of $80M across 3 funding rounds to date. The company's 1st funding round was a $***** PE round, raised on Feb 19, 1983.

When was the latest funding round of Biogen?

Biogen's latest funding was a $***** Post IPO round on Feb 13, 2024, with participation from 1 investor.

What is the annual revenue of Biogen?

Annual revenue of Biogen is more than $1B as on Dec 31, 2025

Where does Biogen rank among its competitors?

Biogen ranks 2nd amongst 3221 active competitors, of which 1098 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Karyopharm, which secured $30M in Mar, 2026.

Who are the top competitors of Biogen?

Biogen's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Abcellera Biologics. Among them, Karyopharm secured the most recent funding round in March, 2026.

Biogen - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of therapies for neurodegenerative and immunology disorders. The company has developed a pipeline of drugs for Alzheimer's disease Amyotrophic lateral sclerosis (ALS), Angelman syndrome, Brain contusion, Multiple sclerosis (MS), Multiple system atrophy (MSA), Ophthalmology, Pain, and more.

Website: www.biogen.com/
Social
Email ID: *****@biogen.com
Phone Number: +1 **********
Registered Address: Cambridge, Massachusetts

Key Metrics

Founded Year

1978

Location

Cambridge, United States

Stage

Public

Total Funding

$80M in 3 rounds

Latest Funding Round

Post IPO, Feb 13, 2024, $*****

Investors

Berkshire Hathaway & 12 more

Ranked

2^nd among 3221 active competitors

Annual Revenue

$1B+ as on Dec 31, 2025

Employee Count

7,805 as on Jul 31, 2026

Investment & Acquisitions

RayThera & 39 more

Similar Companies

Jazz Pharmaceuticals & 1092 more

Exit Details

Public

View Biogen's full profile

Biogen is associated with 7 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Biogen Inc. CIN: 875045 , United States, Active	Sep 22, 2014	$1B+ (As on Dec 31, 2025)	-	-
BIOGEN IDEC BIOTECH INDIA PRIVATE LIMITED CIN: U24232DL2007PTC305611 , India, Active	Mar 01, 2007	0 - ₹10 Cr (As on Mar 31, 2025)	-
Biogen Idec Inc. CIN: 330112644 , United States, Active	Dec 31, 1999	$1B+ (As on Dec 31, 2014)	4289 (As on Dec 31, 2024)	-
BIOGEN CAPABILITY CENTER INDIA PRIVATE LIMITED CIN: U62013KA2023FTC173057 , India, Active	Apr 30, 2023	₹50 - ₹100 Cr (As on Mar 31, 2025)	-
Biogen Estonia OÜ CIN: 14996084 , Estonia, Active	Jun 24, 2020	-	1 (As on Sep 30, 2024)
BIOGEN PHARMA D.O.O. CIN: 76730068664 , Croatia, Active	Feb 17, 2020	€0 - €1M (As on Dec 31, 2024)	-
Biogen Ma Inc. CIN: 20151245297 , United States, Active	Apr 08, 2015	-	-	-

Biogen got listed on Sep 16, 1991.

Click here to take a look at Biogen's IPO in detail

Biogen has raised a total funding of $80M over 3 rounds. Its first funding round was on Feb 19, 1983. Its latest funding round was a Post IPO round on Feb 13, 2024 for $*****. 1 investor participated in its latest round. Biogen has 13 institutional investors.

Here is the list of recent funding rounds of Biogen:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 13, 2024	2096339	Post IPO	6957761	7144022	3615012	5870679
Jul 27, 2010	2525759	Grant (prize money)	3748511	9697858	8045721	HHS
Feb 19, 1983	8177108	PE	8182539	2978436	7565030	6664156

Access funding benchmarks and valuations. Sign up today!

View details of Biogen's funding rounds and investors

The founders of Biogen are Phillip Allen Sharp, Charles Weissmann, Heinz, Walter Gilbert and Kenneth Murray.

Here are the details of Biogen's key team members:

Phillip Allen Sharp: Co-Founder of Biogen and founder of 1 other company.
Contact Info: 1 email address
Charles Weissmann: Co-Founder of Biogen.
Contact Info: 1 email address
Heinz: Co-Founder of Biogen.
Walter Gilbert: Co-Founder of Biogen.
Kenneth Murray: Former Co-Founder of Biogen.

View details of Biogen's Founder profiles and Board Members

Biogen's employee count trend

Biogen has 7,805 employees as of Jul 26. Here is Biogen's employee count trend over the years:

Uncover Biogen's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biogen include Jazz Pharmaceuticals, PTC Therapeutics and Abcellera Biologics. Here is the list of Top 10 competitors of Biogen, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Biogen 1978, Cambridge (United States), Public	Developer of therapies for neurodegenerative and immunology disorders	$80M	Berkshire Hathaway, Digital Pharma Lab & 11 others	78/100
3rd	PTC Therapeutics 1998, South Plainfield (United States), Public	Developer of small molecule drugs for the treatment of rare diseases	$248M	HBM Healthcare Investments, Credit Suisse First Boston ... & 28 others	77/100
4th	Abcellera Biologics 2012, Vancouver (Canada), Public	AI-enabled platform for antibodies discovery	$115M	DCVC, Orbimed & 16 others	76/100
5th	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Google Ventures, Baillie Gifford & 17 others	75/100
6th	argenx 2008, Ghent (Belgium), Public	Developer of antibody-based drugs to treat autoimmune diseases and cancer	$61.9M	Life Sciences Partners, PMV & 20 others	74/100
7th	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	72/100
8th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
9th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
10th	Karyopharm 2008, Newton (United States), Public	Biopharmaceutical company focused on developing and commercializing innovative cancer therapies	$98.4M	Foresite Capital, Avidity Partners & 16 others	71/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Biogen's competitors? Click here to see the top ones

Biogen has made 29 investments in companies including Dayra Therapeutics and Autobahn Therapeutics. Biogen has also acquired 11 companies including RayThera and Apellis Pharmaceuticals.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jun 17, 2026	Acquisition	RayThera	2023	San Diego (United States)
Mar 31, 2026	Acquisition	Apellis Pharmaceuticals	2008	Crestwood (United States)
Nov 24, 2025	Investments	Dayra Therapeutics		San Francisco (United States)